Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-866 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
filingDate |
2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fef63c9c08ae64574db1bf17556fa32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9861a2d09d190f391e3dc28fa6666194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35f98e3488a7c7f74813f52016e5ed7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5f2d2a76b83cccc279bb97180635f80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4afee3e78137bc12f60475e799226b9 |
publicationDate |
2017-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20170123704-A |
titleOfInvention |
Treatment of patients with type 2 diabetes |
abstract |
The present invention relates to riccisanide for use in reducing the progression of urinary albumin excretion in patients with type 2 diabetes. |
priorityDate |
2015-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |